Loncar Cancer Immunotherapy ETF
Health/Biotechnology
CNCR
, ,
Price
-
$ 12.52
0 %
-0.09
Feb 20, 2025
- Last Close
- Net Assets
- 52-Week High/Low
- $17.62 - $11.33
- Expense Ratio
- -
Returns +
Q
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Q1 | - | 23.4% | -12.7% | -24.4% | 17% | -16.7% |
| Q2 | - | -5% | 7.8% | -15.6% | 4.3% | 38.7% |
| Q3 | - | - | -15.2% | -3.6% | -0.7% | 171.1% |
| Q4 | - | - | 28% | -6.3% | 8.2% | -41.5% |
Returns +
M
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | 4.8% | 22.2% | -3.6% | -11.9% | -0.6% | - | - | - | - | - | - | - |
Returns +
A
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 8% | -1.9% | -42.3% | -44.6% | 83.3% | 24.2% | -20.6% | 13.6% | -25.6% | 2.4% |